Full Press Release Details
Ranked in Deloitte's Technology Fast 500
MT, November 19, 2013 -- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary
bone graft material and coatings for medical applications, today announced it ranked on Deloitte's
Technology Fast 500TM, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and
clean technology companies in North America.
are excited to among the fastest growing companies and identified as an innovative leader in our sector," commented
Dan Goldberger, President and Chief Executive Officer of Bacterin International Holdings. "This
is indeed an honor we appreciate as we continue to innovate and grow our business."
2013 Deloitte Technology Fast 500 companies are exemplary cases of those spurring growth in a tough market through innovation,"
said Eric Openshaw, vice chairman, Deloitte LLP and U.S. technology, media
and telecommunications leader. "This year's
list is a who's who of companies behind the most exciting
and innovative products and services in the technology space. We congratulate the Fast 500 companies and look forward to what they
Award winners were selected
based on percentage fiscal year revenue growth from 2008 to 2012.
About Bacterin International
Bacterin International
Holdings, Inc. (NYSE MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's
proprietary methods optimize the growth factors in human allografts to promote bone, subchondral repair and dermal growth. These
products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone
growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other
Bacterin's Medical Device
division develops, employs, and licenses coatings for various medical device applications. For further information, please visit
Important Cautions Regarding Forward-looking
This news release contains certain disclosures
that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are
subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that
depend upon or refer to future events or conditions, or that include words such as "continue," "efforts," "expects,"
"anticipates," "intends," "plans," "believes," "estimates," "projects,"
"forecasts," "strategy," "will," "goal," "target," "prospects," "potential,"
"optimistic," "confident," "likely," "probable" or similar expressions or the negative
thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by
their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors,
including, among others: the Company's ability to launch beta and full product releases; the Company's ability to meet its obligations
under existing and anticipated contractual obligations; the Company's ability to develop, market, sell and distribute desirable
applications, products and services and to protect its intellectual property; the ability of the Company's sales force to achieve
expected results; the ability of the Company's customers to pay and the timeliness of such payments, particularly during recessionary
periods; the Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's
ability to attract and retain management and employees with appropriate skills and expertise; the impact of changes in market,
legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other factors.
Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading
"Risk Factors." The Company undertakes no obligation to release publicly any revisions to any forward-looking statements
to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required